Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2024-03-04 LO FRANCIS Chief People Officer Grant or award +99,976 268,445
2024-03-04 LO FRANCIS Chief People Officer Grant or award · Stock Option (right to buy) +150,024 150,024
2024-03-04 BENZENO SHARON Chief Commercial Ofc Imm Med Grant or award +132,979 356,805
2024-03-04 BENZENO SHARON Chief Commercial Ofc Imm Med Grant or award · Stock Option (right to buy) +199,549 199,549
2024-03-04 RUBINSTEIN JULIE President Grant or award +175,000 511,824
2024-03-04 ROBINS HARLAN S Chief Scientific Officer Grant or award +354,610 1,021,180
2024-03-04 PETERSON TYCHO Chief Financial Officer Grant or award +147,790 547,009
2024-03-04 ROBINS CHAD M CEO and Chairman Grant or award +354,610 2,625,374
2024-03-04 BOBULSKY SUSAN Chief Commercial Officer, MRD Grant or award +132,979 261,281
2024-03-04 BOBULSKY SUSAN Chief Commercial Officer, MRD Grant or award · Stock Option (right to buy) +199,549 199,549
2023-12-13 NEUPERT PETER M Director Option exercise +100,000 $0.84 $84K 122,968
2023-12-13 NEUPERT PETER M Director Option exercise · Stock Option (right to buy) −100,000 0
2023-11-16 PISKEL KYLE Principal Accounting Officer Sale −259 $4.13 $1K 87,305
2023-08-08 SOOD NITIN Chief Commercial Officer, MRD Sale 10b5-1 −10,550 $6.54 $69K 214,808
2023-08-07 SOOD NITIN Chief Commercial Officer, MRD Sale 10b5-1 −5,652 $6.78 $38K 225,358
2023-06-20 PETERSON TYCHO Chief Financial Officer Option exercise 10b5-1 +134,961 $7.30 $985K 534,180
2023-06-20 PETERSON TYCHO Chief Financial Officer Sale 10b5-1 −70,000 $8.14 $570K 464,180
2023-06-20 PETERSON TYCHO Chief Financial Officer Sale 10b5-1 −64,961 $8.14 $529K 399,219
2023-06-20 PETERSON TYCHO Chief Financial Officer Option exercise · Stock Option (right to buy) 10b5-1 −134,961 447,868
2023-06-15 PETERSON TYCHO Chief Financial Officer Sale 10b5-1 −55,672 $8.53 $475K 399,219

Page 31 of 120 · 2,386 trades